Diphenhydramine Completed Phase 4 Trials for Allergic Conjunctivitis (AC) Treatment

Indications	Status	Purpose	Phase
DBCOND0076634 (Allergic Conjunctivitis (AC))	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00689078	Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model	Diphenhydramine (DB01075) Loteprednol etabonate (DB14596) Prednisolone acetate (DB15566)